Publication:

Arterial Spin Labeling Blood Flow MRI: Its Role in the Early Characterization of Alzheimer's Disease

Loading...
Thumbnail Image

Date

2010-05-26

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

IOS Press
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Alsop, David C., Weiying Dai, Murray Grossman, and John A. Detre. “Arterial Spin Labeling Blood Flow MRI: Its Role in the Early Characterization of Alzheimer’s Disease.” Edited by Jack C. de la Torre. Journal of Alzheimer’s Disease 20, no. 3 (May 26, 2010): 871–80. https://doi.org/10.3233/JAD-2010-091699.

Abstract

Arterial spin labeling (ASL) enables the noninvasive, quantitative imaging of cerebral blood flow using standard magnetic resonance imaging (MRI) equipment. Because it requires no contrast injection, ASL can add resting functional information to MRI studies measuring atrophy and signs of ischemic injury. Key features of ASL technology that may affect studies in Alzheimer’s disease are described. The existing literature describing ASL blood flow imaging applied to Alzheimer’s disease and related dementia is reviewed, and the potential role of ASL in treatment and prevention studies of early Alzheimer’s disease is discussed.

Description

Research Data

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories